Genetic factors play an important role in many types of epilepsy. Single gene mutations can cause monogenic forms of epilepsy, which are often inherited in an autosomal dominant or recessive pattern. These include mutations in ion channel genes like SCN1A, KCNQ2/3, GABRA1, and CLCN2. Non-ion channel gene mutations have also been linked to progressive myoclonic epilepsies. Chromosomal abnormalities, mitochondrial disorders, and inherited metabolic conditions additionally confer higher epilepsy risk. Environmental influences can also contribute to multifactorial, polygenic forms of epilepsy.
This presentation summarises the importance of genetics in epilepsy, whom to test, and the various tests available. It looks at the role of genetics in various forms of epilepsy and recent advances in precision medicine.
This presentation summarises the importance of genetics in epilepsy, whom to test, and the various tests available. It looks at the role of genetics in various forms of epilepsy and recent advances in precision medicine.
This presentation looks at abnormal EEG patterns with examples for each. Benign variants, artifacts and focal ictal patterns are not part of this presentation.
This is a brief review of autoimmune epilepsies, especially autoimmune encephalitis, SREAT, NORSE, FIRES and Rasmussen's encephalitis. A brief overview of investigations and treatment is included.
This presentation looks at generalised periodic epileptiform discharges and the various disorders like Creutzfeldt Jacob disease (CJD), SSPE and metabolic encephalopathies in which it is seen. SIRPID is also discussed. Triphasic waves are described. Radermacker complexes in SSPE are described.
Epileptogenesis is the process by which a brain network that was previously normal is functionally altered toward increased seizure susceptibility, thus having an enhanced probability to generate spontaneous recurrent seizures (SRSs). The process of epileptogenesis occurs in 3 phases: the occurrence of a precipitating injury; a 'latent' period of epileptogenesis and chronic, established epilepsy. Structural and molecular changes associated with epileptogenesis include selective neuronal loss,axonal and dendritic reorganisation, neurogenesis, altered expression of neurotransmitters, and changes at glial architecture. Antiepileptogenesis can be complete or partial. Complete prevention aborts the development of epilepsy while partial prevention can delay the development of epilepsy or reduce its severity. Targeting signaling pathways that alter the expression of genes involved in epileptogenesis may provide novel therapeutic approaches for preventing epileptogenesis. The mTOR and REST pathways are exciting new potential targets for intervention in the epileptogenic process.
This presentation looks at abnormal EEG patterns with examples for each. Benign variants, artifacts and focal ictal patterns are not part of this presentation.
This is a brief review of autoimmune epilepsies, especially autoimmune encephalitis, SREAT, NORSE, FIRES and Rasmussen's encephalitis. A brief overview of investigations and treatment is included.
This presentation looks at generalised periodic epileptiform discharges and the various disorders like Creutzfeldt Jacob disease (CJD), SSPE and metabolic encephalopathies in which it is seen. SIRPID is also discussed. Triphasic waves are described. Radermacker complexes in SSPE are described.
Epileptogenesis is the process by which a brain network that was previously normal is functionally altered toward increased seizure susceptibility, thus having an enhanced probability to generate spontaneous recurrent seizures (SRSs). The process of epileptogenesis occurs in 3 phases: the occurrence of a precipitating injury; a 'latent' period of epileptogenesis and chronic, established epilepsy. Structural and molecular changes associated with epileptogenesis include selective neuronal loss,axonal and dendritic reorganisation, neurogenesis, altered expression of neurotransmitters, and changes at glial architecture. Antiepileptogenesis can be complete or partial. Complete prevention aborts the development of epilepsy while partial prevention can delay the development of epilepsy or reduce its severity. Targeting signaling pathways that alter the expression of genes involved in epileptogenesis may provide novel therapeutic approaches for preventing epileptogenesis. The mTOR and REST pathways are exciting new potential targets for intervention in the epileptogenic process.
It is about the mutagens that causes the genetic disorders. Here I enlist the different responsible proteins whose deficiency or excessive amount cause genetic disorders.
Etude des canaux ioniques intérêts pour la physiopathologie et le traitement ...Pasteur_Tunis
Présentation de Arnaud Monteil réalisée durant le cours du réseau international des instituts Pasteur de "Médecine Génomique: du diagnostic à la thérapie " (17-21 octobre 2016)
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
2. What role do genetics play in epilepsy?
• Genetics play a part in many types of epilepsy. It seems likely that the seizure threshold, for
example, is partly determined by genetics. Epilepsy often runs in families:
• • If a parent has idiopathic epilepsy, there is about a 9% to 12% chance that the child will also have
epilepsy.
• • if a child has epilepsy, his brothers and sisters do have a higher risk of having epilepsy.
• • If one twin has idiopathic epilepsy, the identical twin is very likely to have it as well.
• • For some reason, children of women with epilepsy have a higher chance of having epilepsy than
children of men with epilepsy.
• Family studies have shown that some epilepsy syndromes are completely determined by genetics,
and genes are a major factor in other syndromes. Some inherited metabolic conditions also raise the
likelihood of having seizures, as do some chromosomal disorders.
3. What types of genetic disorders are there?
There are five types of genetic disorders:
• Single gene or Mendelian disorders (Monogenic). A single mutated gene is
sufficient to cause the phenotype. Single gene disorders are typically described
as inherited in families, since they are passed from one generation to the next.
• Multifactorial or complex disorders. These are related to mutations in a
number of genes (polygenic), often coupled with an environmental influence.
Environmental factors include things like alcohol or drug use, maternal
infections, and exposure to hazardous materials. These disorders tend to run in
families, although a pattern of inheritance is often difficult to identify.
4. • Mitochondrial disorders. These disorders result from mutations in DNA
found outside the cell nucleus in mitochondria. Mitochondria are structures that make
energy for the cells. If there is a mitochondrial gene mutation, energy production is
affected. The DNA in mitochondria is inherited only from the mother.
• Chromosomal disorders. These disorders result when entire chromosomes or
parts of chromosomes are missing or changed. Chromosomal disorders usually occur
spontaneously, however, on rare occasions they are inherited.
• Epigenetic disorders. These are disorders related to changes in the activity of
genes, rather than a mutation in the structure of the DNA
6. Classification of Single gene mutation
(monogenic)
A-Ion channels implicated in human epilepsy
I. Autosomal dominant inheritance
1. Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE)
2. Benign familial neonatal convulsion (BFNC)
3. Generalized epilepsy with febrile seizures plus (GEFS+)
4. Juvenile myoclonic epilepsy (JME)
5. Autosomal dominant idiopathic generalized epilepsy
7. Classification of Single gene mutation
(monogenic)
II. Sporadic
1. Severe myoclonic epilepsy of infancy
III.Other ion channel gene implicated in epilepsy (mutation identified
in small number of patients, so role in epilepsy less clear)
1. Episodic ataxia type 1 and type 2
8. Classification of Single gene mutation
(monogenic)
• B- Single Non ion channel gene mutation implicated in epilepsy
1. Progressive myoclonic epilepsy (PME)
2. Autosomal dominant partial epilepsy with auditory features (ADPEAF)
• C- single gene mutation with high risk of developing epilepsy
9. Ion channels implicated in human epilepsy (AD)
• 1-Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE)
• Feature:- characterized by childhood onset of clusters of sleep-related
seizures with predominant motor and dystonic features.
• Gene , locus and protein
CHRNA4 20q13 Ach receptor α4 subunit
CGRNB2 1q21 Ach receptor β2 subunit
10. The neuronal nicotinic acetylcholine receptors (nAChRs) (CHRNA4/CHRNB2) are pentamers, with each subunit containing four transmembrane
domains. At least ten nAChR subunits, which can assemble into heteromeric (α2–α6, β2–β4) or homomeric receptors ((α 7, (α 9), are expressed in the
human brain. The binding of two agonist molecules is required for channel opening. The channel itself shows little selectivity among monovalent cations
11. Ion channels implicated in human epilepsy (AD)
• 2- Benign familial neonatal convulsion (BFNC)
• Feature:- is a rare, highly penetrant, autosomal dominant disorder with short-lasting
multifocal or generalized seizures beginning between a few days of life and three
months of age. A few patients will manifest isolated seizures later in life.
• locus , Gene , and protein
• 20q13 KCNQ2 M-current potassium channel
• 8q24 KCNQ3 M-current potassium channel
12. Voltage-gated potassium channels (KCNQ2/KCNQ3) are tetramers made up from homologous subunits. Each subunit contains six transmembrane
domains. The fourth transmembrane domain carries several positively charged amino acids, which cause a conformational change on membrane
depolarization. The linker between transmembrane domains 5 and 6 contains the selectivity filter that lines the ion pore
13. Ion channels implicated in human epilepsy (AD)
• 3-Generalized epilepsy with febrile seizures plus (GEFS+)
• Feature:- GEFS+ encompasses a spectrum of childhood-onset epilepsy phenotypes including FS and
FS+ (when afebrile seizures occur and/or FS continue past age six years). Other less-common
phenotypes are FS+ with absence, myoclonic or atonic seizures, partial epilepsies, myoclonic astatic
epilepsy (MAE) and severe myoclonic epilepsy in infancy
• locus , Gene , and protein
• 2q24 SCN1A Voltage-gated sodium channel α1 subunit
19q13 SCN1B Voltage-gated sodium channel β1 subunit
2q23 SCN2A Voltage-gated sodium channel α2 subunit
5q31 GABRG2 GABAA receptor subunit (discuss in JME)
14.
15. Voltage-gated sodium channels (SCN1A/SCN2A) are built from one α-subunit, which contains four tandem domains, each resembling the
structure of a voltage-gated potassium channel subunit. Sodium channels are associated with two accessory β subunits, which accelerate the
gating kinetics of the channel.
16. Ion channels implicated in human epilepsy (AD)
• 4-Juvenile myoclonic epilepsy (JME)
• Feature:- Juvenile myoclonic epilepsy usually appears in adolescents between 12 and 18 years
old. People with this syndrome have myoclonic jerks, usually in the shoulders and arms, upon
awakening or shortly afterward. Half of patients with this condition have relatives with
epilepsy. The genetic basis of this syndrome is complex and the mechanism of transmission is
unclear.
• locus , Gene , and protein
• 5q34-q35 GABRA1 GABA A receptor a1 subunit
17.
18. The GABAA (γ-aminobutyric acid, subtype A) receptors (GABRG2/GABRA1) are ligand-gated ion channels that probably evolved from the same
ancient genes as the nAChRs, with whom they share several features, such as four transmembrane domains per subunit and a pentameric structure.
GABAA receptors are selective for small anions and allow both chloride and bicarbonate to permeate
19. Ion channels implicated in human epilepsy (AD)
5- autosomal dominant idiopathic generalized epilepsy
• locus , Gene , and protein
• 3q26 CLCN2 Chloride channels
20. Voltage-gated chloride channels of the CLCN type comprise a gene family with nine
mammalian members. They build homodimeric proteins, which probably contain two
separate pores. CLCN channels conduct chloride ions across cell membranes, governing the
electrical activity of cells.
21. Ion channels implicated in human epilepsy (sporadic)
1. Severe myoclonic epilepsy of infancy (Dravet’s syndrome)
• Feature:- Severe myoclonic epilepsy of infancy (SMEI) is an epileptic encephalopathy
beginning in infancy with prolonged clonic febrile and afebrile seizures and is
subsequently associated in most children with myoclonic, atypical absence and sometimes
focal seizures Sporadic SMEI has been associated with de novo SCN1A mutations in
30% of patients
• Gene , locus and protein
SCN1A 2q24 Sodium channel subunit
22.
23. Voltage-gated sodium channels (SCN1A/SCN2A) are built from one α-subunit, which contains four tandem domains, each resembling the
structure of a voltage-gated potassium channel subunit. Sodium channels are associated with two accessory β subunits, which accelerate the
gating kinetics of the channel.
24.
25. Other ion channel gene implicated in epilepsy (mutation identified in small number of
patients, so role in epilepsy less clear)
1- Episodic ataxia type 1 and 2 (EA1,2)
Gene , locus and protein
In EA1 KCNA1 12p13 Potassium channel subunit
In EA2 CACNA1A 19p13 Calcium channel subunit
26. Single Non ion channel gene mutation
implicated in epilepsy
1-Progressive myoclonus epilepsies (PMEs)
• The progressive myoclonus epilepsies (PMEs) are a group of rare disorders in which there is
progressive neurological deterioration together with myoclonus (twitching) and epilepsy. Several
PMEs have autosomal recessive inheritance, including:
A- AD as
1. dentatorubral-pallidoluysian atrophy (DRPLA),
B- AR as
1. Unverricht-Lundborg disease
2. Sialidosis or cherry-red spot myoclonus
3. Lafora’s disease
4. Neuronal ceroid lipofuscinosis (NCL or Batten’s disease)
27. phenotype Mood of
inheritance
feature gene locus protein
dentatorubral-
pallidoluysian
atrophy
AD appears before age 30; affected
people have muscle twitches,
epilepsy, dementia, ataxia , and
choreoathetosis
CAG expansion in a gene on
12p13.31
Unverricht-
Lundborg disease
AR Usually presents in childhood
with stimulus sensitive and
spontaneous myoclonus, tonic-
clonic seizures, ataxia, and mild
cognitive decline
cystatin B
gene
21q22.3 protease
inhibitor
Sialidosis or cherry-
red spot myoclonus
AR Storage disese the sialidase gene on 6p21.3.
28. phenotype Mood of
inheritance
feature gene locus protein
Lafora’s disease AR Myoclonic epilepsy with onset in
the second decade, associated
with visual hallucinations and
cognitive decline. The
characteristic carbohydrate
accumulations (Lafora bodies)
EPM2A/
EPM2B
6q24 Laforin is
a tyrosine
phosphata
se
Neuronal ceroid
lipofuscinosis
(NCL or Batten’s
disease)
AR associated with early visual
impairment, cognitive decline,
and spasticity
1-palmitoyl-protein thioesterase gene
(1p32), causing either infantile or
juvenile-onset NCL
2- the tripeptidyl peptidase 1 gene
(11q15) and associated with late infantile
onset NCL
3- CLN3 gene on 16p associated with a
juvenile-onset form
29. Single Non ion channel gene mutation
implicated in epilepsy
2-Autosomal dominant partial epilepsy with auditory features (ADPEAF)
• Feature:- familial temporal lobe epilepsy (FTLE) includes mesial and lateral forms. The lateral
FTLE [autosomal dominant partial epilepsy with auditory features (ADPEAF)] begins in
childhood–adolescence with auditory hallucinations, alone or with other sensory (olfactory,
vertiginous, visual) symptoms. Mesial FTLE has childhood onset and seizures have mesial temporal
lobe auras, including de ´ja ` vu, perceptual changes or autonomic phenomena No loci have been
found.
• Gene , locus and protein
ADPEAF 10q24 LGI1 Leucine-rich glioma inactivated 1
Functional inactivation of one allele led to ADPEAF, whereas silencing of both alleles was observed
in several high-grade gliomas.
30. LGI1 is secreted from the presynapse and binds to postsynaptic ADAM22. Binding to ADAM22 results in altered
intracellular signalling in the postsynapse that decreases excitability, probably through subunit changes in
postsynaptic glutamate receptors. Mutations in LGI resulting in lack of ADAM22-mediated signalling therefore
result in a net increase in excitability.
31. Epitempin repeat in epilepsy-associated genes. The proteins encoded by both LGI1, the gene involved in autosomal
dominant lateral temporal lobe epilepsy, and the MASS1/VLGR1 gene, which is mutated in the Frings mouse model for
audiogenic seizures and in one family with febrile seizures, share the epitempin repeat. The MASS1/VLGR1 protein — one
of the largest membrane proteins and a member of the superfamily of seven-helix G-protein coupled receptors — contains
six complete and one degenerate copy of the epitempin repeat. MASS1/VLGR1 is expressed in the developing nervous
system rather than in the adult brain. Its overall structure shows homologies to large G protein coupled receptors from the
flamingo family, the latrophilins and the brain angiogenesis inhibitors. These receptors are mainly involved in neuronal
development. Furthermore, the leucine-rich repeat (LRR) domain subtype present in the LGI1 protein is also found in Slit, a
neurogenic protein involved in axonal guidance. It is therefore tempting to speculate that both MASS1/VLGR1 and LGI1
cause epilepsy by interference with normal brain development. aa, amino acid residues; TM, transmembrane domain
32. Other single gene disorders that can manifest
as epilepsy
• Tuberous sclerosis
• Tuberous sclerosis (TS) is a frequent cause of malignant childhood epilepsy, in particular
West syndrome (hypsarrhythmia, mental retardation, and infantile spasms). Approximately
half of patients with TS are familial cases, and the other half are sporadic. TS is caused by
dominant mutations of one or other of two tumour suppressor genes (TSC1 and TSC2
located on 9q34 and 16p13.3, respectively) Approximately 80% of people with tuberous
sclerosis develop epilepsy
• Neurofibromatosis 1 (NF-1)
• Approximately 3% to 13% of people with NF-1 develop epilepsy, although with a far better
prognosis than TS.
33. .
Fragile X syndrome
Fragile X syndrome is caused by a gene mutation on the X chromosome. It causes mild
to severe intellectual disability, and approximately 20% to 40% of people with the
condition will also develop epilepsy. If a father has fragile X syndrome, he will pass a
milder form of the disorder to his daughters but will not pass it to his sons. If a mother
has fragile X syndrome, her children have a 50% chance of inheriting it. The gene is
often passed down in a milder form, so that families may be unaware that they carry it.
34.
35. Rett syndrome
Rett syndrome is caused, in most cases, by a newly discovered mutation on the X
chromosome. In a few families, the syndrome is inherited in an X-linked dominant
pattern. It was initially believed that Rett syndrome affects only girls; however, it has
recently been found to occur rarely in boys as well. The disorder usually develops
between one and two years of age. Children with the disorder have epilepsy in 70% to
80% of cases, together with other problems such as constant hand-wringing, difficulty
walking, developmental disability and autism.
Acute intermittent porphyria
Acute intermittent porphyria is a rare disease caused by a gene mutation in the HMBS
gene on chromosome 11, which controls a step in the production of hemoglobin. The
symptoms of the condition consist of severe attacks of abdominal pain, vomiting,
digestive problems, and seizures. The attacks are triggered by factors such as certain
drugs, smoking, dieting, other illnesses, and stress.
36.
37. Leukodystrophies
Leukodystrophies are disorders affecting the production or maintenance of
the fatty covering of nerves. As a result, signals travel more slowly than
normal through the nervous system. This disrupts the functioning of the
nervous system, which can sometimes include seizures. Leukodystrophies
can be caused by mutations in many different genes; their inheritance
pattern depends on which gene is affected. In some cases, the mutation
arises spontaneously. More than 30 leukodystrophies have been identified.
Some specific leukodystrophies are Alexander disease, Canavan disease,
and Krabbe disease.
38. inherited metabolic conditions
A number of inherited metabolic conditions may cause seizures, including:
• aminoacidopathies such as phenylketonuria (PKU) and maple syrup urine
disease
• galactosemia
• lysosomal lipid storage diseases such as Tay-Sachs disease
• peroxisomal disorders
• pseudohypoparathyroidism
• pyridoxine dependency
40. Multifactorial disorders
• A number of epilepsy syndromes are thought to be multifactorial or complex
disorders, in which genetic and environmental factors both seem to play a part.
• Among epilepsies with complex inheritance, IGEs seem very suitable for genetic
studies because they are common. BUT the unknown mode of inheritance, the
heterogeneity of the epilepsy phenotypes, the uncertainty of the genetic overlapping
of IGE sub-syndromes and the lack of large families are major obstacles to the
study of the genetic architecture of IGE
41. Myoclonic-astatic epilepsy
Myoclonic-astatic epilepsy usually appears between two and five years of age, with a variety
of seizure types. The relatives of affected children often have other forms of epilepsy or
febrile seizures, suggesting a strong genetic component. It is possible that several different
genes are involved, as well as other modifying factors.
Benign epilepsy of childhood with centrotemporal spikes (BECTS)
Benign epilepsy of childhood with centrotemporal spikes (BECTS), also known as benign
rolandic epilepsy, is one of the most common childhood epilepsy syndromes. It usually
begins between ages five and 10 years and disappears in adolescence.
Benign myoclonic epilepsy of infancy
Benign myoclonic epilepsy of infancy is a rare condition that usually affects children
between six months and three years old. Children with the syndrome have brief
myoclonicseizures that are usually easy to control with medication. In about 30% of cases,
other family members also have some form of epilepsy or febrile convulsions.
42. Juvenile myoclonic epilepsy
Juvenile myoclonic epilepsy usually appears in adolescents between 12 and 18 years old.
People with this syndrome have myoclonic jerks, usually in the shoulders and arms, upon
awakening or shortly afterward. Half of patients with this condition have relatives with
epilepsy. The genetic basis of this syndrome is complex and the mechanism of
transmission is unclear. It is possible that several different genes are responsible.
Childhood absence epilepsy
Childhood absence epilepsy begins between four and 10 years old, and involves severe
and frequent absence seizures. In up to 44% of cases, other family members also have
epilepsy. Some researchers have found links to chromosome 1 or chromosome 8.
However, it seems likely that other factors besides genetics are involved.
Juvenile absence epilepsy
Juvenile absence epilepsy is similar to childhood absence epilepsy, but usually begins later
in life, between 10 and 17 years old. Some children with this syndrome have family
members with epilepsy.
44. Mitochondrial disorders
• Myoclonus epilepsy and ragged-red fibres (MERRF)
Myoclonus epilepsy and ragged-red fibres (MERRF) is a progressive myoclonus
epilepsy that is caused by missense mutations in the mitochondrial gene coding
for lysine tRNA. People with this syndrome manifest it in a wide variety of
ways; some are unaffected, some develop epilepsy later in life, and others
develop severe, progressive epilepsy with dementia as children. The mutation is
passed from mother to child.
46. Chromosomal disorders
1- Down syndrome
Down syndrome is caused by an additional copy of chromosome 21. This means that
instead of the normal pair of chromosomes, there are 3 copies. This is called a
trisomy. Down syndrome is also referred to as Trisomy 21. A trisomy is caused by an
error that occurs during cell division. Approximately 2% to 15% of people with Down
syndrome develop epilepsy.
• Other trisomies
Other trisomies that can result in epilepsy in 20% to 25% of cases are trisomy 18
(Edwards syndrome), trisomy 13 (Patau syndrome), and trisomy 22.
48. 3- Angelman syndrome
Angelman syndrome is caused by a deletion on one arm of the copy of chromosome 15 that came from the
person’s mother. More than 80% of people with this condition develop seizures, usually by age three.
49. 4- Ring chromosome abnormalities
Ring chromosome abnormalities are rare disorders that occur when both ends of
a chromosome are damaged and the chromosome reforms in a ring shape. Ring
chromosome abnormalities, including ring chromosomes 6, 9, 14, 15, and 20,
account for 2% to 3% of cases of epilepsy, although not all people with these
conditions have seizures.